8-K
Current Report
Aligos Therapeutics, Inc. Filed Acc 0001193125-24-202813
Shareholder rights changed · Bylaws or fiscal year change
- Item 3.03 Material modification to rights of security holders
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading d882619d8k.htm…